Laboratory Medicine

Test catalogue

Infliximab (Remicade) Antibodies
Test Name Infliximab (Remicade) Antibodies
Specimen Type / Requirements Container Type = 1 Red top or Lavender top. Minimum Testing Volume = 2mL Serum or Plasma (EDTA) Tubes must fill to at least ½ or greater of its vacuum capacity
Specimen Handling Collection Instructions: Collect fasting specimen. Pre-chill tube at 4°C before drawing the specimen. Draw into the pre-chilled tube, and then chill tube in wet ice for 10 minutes. Write your initials, date and time of collection on the collection label. Laboratory Staff Instructions: Maintain at 4°C up to 6 hours prior to separation. Submit two specimens (minimum 1 mL each). Store and send frozen. Rejection Criteria: Unlabeled or samples of non sufficient quantity. Stability: Stable refrigerated for 24 hours and Frozen for 2 months. Transportation: Send sample to core lab as soon as possible.
Required Documentation
Turnaround Time (TAT) 14 days	Test Utilization
Reference Value Infliximab Antibodies: < 2 µg/mL to < 25 AU/mL
Test code MISCS	Methodology ELISA
Testing Location Referred Out – ON, Canada (ROICL02)	Other Information Last Updated: November 07, 2022

Infliximab (Remicade) Antibodies

Test Name

Infliximab (Remicade) Antibodies

Specimen Type / Requirements

Container Type = 1 Red top or Lavender top.

Minimum Testing Volume = 2mL Serum or Plasma (EDTA)

Tubes must fill to at least ½ or greater of its vacuum capacity

Specimen Handling

Collection Instructions: Collect fasting specimen. Pre-chill tube at 4°C before drawing the specimen. Draw into the pre-chilled tube, and then chill tube in wet ice for 10 minutes. Write your initials, date and time of collection on the collection label.

Laboratory Staff Instructions: Maintain at 4°C up to 6 hours prior to separation. Submit two specimens (minimum 1 mL each). Store and send frozen.

Rejection Criteria: Unlabeled or samples of non sufficient quantity.

Stability: Stable refrigerated for 24 hours and Frozen for 2 months.

Transportation: Send sample to core lab as soon as possible.

Required Documentation

Turnaround Time (TAT)

14 days

Test Utilization

Reference Value

Infliximab Antibodies: < 2 µg/mL to < 25 AU/mL

Test code

MISCS

Methodology

ELISA

Testing Location

Referred Out – ON, Canada (ROICL02)

Other Information

Last Updated: November 07, 2022